Preservation solutions for cardiac and pulmonary donor grafts: A review of the current literature

Journal of Thoracic Disease

Volumn 6, Issue 8, 2014, Pages 1143-1149

  Latchana, Nicholas ^a   Peck, Joshua R ^b   Whitson, Bryan ^b,c   Black, Sylvester M ^a,c  

^a Transplantation Division   (United States)

^b Department of Surgery   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Cardiac; Donor; Preservation; Pulmonary; Transplantation

Indexed keywords

ANTIOXIDANT; BUFFER; CELSIOR; HTK SOLUTION; PAPWORTH; PERFADEX; PLEGISOL; PRESERVATION SOLUTION; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ALLOGRAFT; ARTICLE; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONSENSUS; GRAFT PRESERVATION; GRAFT SURVIVAL; HEART PRESERVATION; HEART TRANSPLANTATION; HUMAN; HYPOTHERMIA; LUNG TRANSPLANTATION; ORGAN DONOR; ORGAN PRESERVATION; UNG PRESERVATION;

EID: 84907015015     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.05.14     Document Type: Article

References (35)

1. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988;45:673-6.
2. Guibert EE, Petrenko AY, Balaban CL, et al. Organ Preservation: Current Concepts and New Strategies for the Next Decade. Transfus Med Hemother 2011;38:125-42.
3. Demmy TL, Biddle JS, Bennett LE, et al. Organ preservation solutions in heart transplantation--patterns of usage and related survival. Transplantation 1997;63:262-9.
4. Mu¨hlbacher F, Langer F, Mittermayer C. Preservation solutions for transplantation. Transplant Proc 1999;31:2069-70.
5. Feng XN, Xu X, Zheng SS. Current status and perspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int 2006;5:490-4.
6. Chambers DJ, Sakai A, Braimbridge MV, et al. Clinical validation of St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol). Eur J Cardiothorac Surg 1989;3:346-52.
7. Divisi D, Montagna P, Jegaden O, et al. A comparative study of Euro-Collins, low potassium University of Wisconsin and cold modified blood solutions in lung preservation in acute autotransplantations in the pig. Eur J Cardiothorac Surg 2001;19:333-8.
8. Aziz TM, Pillay TM, Corris PA, et al. Perfadex for clinical lung procurement: is it an advance? Ann Thorac Surg 2003;75:990-5.
9. Roskott AM, Nieuwenhuijs VB, Dijkstra G, et al. Small bowel preservation for intestinal transplantation: a review. Transpl Int 2011;24:107-31.
10. 't Hart NA, Leuvenink HGD, Ploeg RJ. New Solutions in Organ Preservation. Transplantation Rev 2002;16:131-41.
11. Marasco SF, Bailey M, McGlade D, et al. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant 2011;30:414-9.
12. Tierney A, Foster R, Ogella D. A perfusionist's role in lung transplant preservation. Perfusion 2004;19:351-7.
13. Wei J, Chang CY, Chuang YC, et al. Successful heart transplantation after 13 hours of donor heart ischemia with the use of HTK solution: a case report. Transplant Proc 2005;37:2253-4.
14. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995;46:235-47.
15. Remadi JP, Baron O, Roussel JC, et al. Myocardial preservation using Celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations. Ann Thorac Surg 2002;73:1495-9.
16. De Santo LS, Amarelli C, Romano G, et al. High-risk heart grafts: effective preservation with Celsior solution. Heart Vessels 2006;21:89-94.
17. Wieselthaler GM, Chevtchik O, Konetschny R, et al. Improved graft function using a new myocardial preservation solution: Celsior. Preliminary data from a randomized prospective study. Transplant Proc 1999;31:2067-8.
18. Vega JD, Ochsner JL, Jeevanandam V, et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 2001;71:1442-7.
19. Cannata A, Botta L, Colombo T, et al. Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg 2012;41:e48-52; discussion e52-3.
20. Kofler S, Bigdeli AK, Kaczmarek I, et al. Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center. Transpl Int 2009;22:1140-50.
21. George TJ, Arnaoutakis GJ, Beaty CA, et al. A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens. J Heart Lung Transplant 2012;31:410-8.
22. Garlicki M, Kołcz J, Rudzin´ski P, et al. Myocardial protection for transplantation. Transplant Proc 1999;31:2079-83.
23. George TJ, Arnaoutakis GJ, Baumgartner WA, et al. Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation. J Heart Lung Transplant 2011;30:1033-43.
24. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081-91.
25. Oto T, Griffiths AP, Rosenfeldt F, et al. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 2006;82:1842-8.
26. Ganesh JS, Rogers CA, Banner NR, et al. Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures. J Thorac Cardiovasc Surg 2007;134:1313-21.
27. Hardesty RL, Aeba R, Armitage JM, et al. A clinical trial of University of Wisconsin solution for pulmonary preservation. J Thorac Cardiovasc Surg 1993;105:660-6.
28. Okada Y, Kondo T. Preservation solution for lung transplantation. Gen Thorac Cardiovasc Surg 2009;57:635-9.
29. Thabut G, Vinatier I, Brugie`re O, et al. Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 2001;164:1204-8.
30. Arnaoutakis GJ, Allen JG, Merlo CA, et al. Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients. J Heart Lung Transplant 2010;29:1380-7.
31. Ga´mez P, Co´rdoba M, Milla´n I, et al. Improvements in lung preservation: 3 years' experience with a low-potassium dextran solution. Arch Bronconeumol 2005;41:16-9.
32. Mu¨ller C, Fu¨rst H, Reichenspurner H, et al. Lung procurement by low-potassium dextran and the effect on preservation injury. Munich Lung Transplant Group. Transplantation 1999;68:1139-43.
33. Rabanal JM, Ibañez AM, Mons R, et al. Influence of preservation solution on early lung function (Euro-Collins vs Perfadex). Transplant Proc 2003;35:1938-9.
34. Stru¨ber M, Wilhelmi M, Harringer W, et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001;19:190-4.
35. Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001;121:594-6.